Skip to content
Search AI Powered

Latest Stories

MHRA's Covid-19 medicines warning

The Medicines and Healthcare products Regulatory Agency (MHRA) has urged the public to remain cautious about the medicines and other medical products being sold on the internet claiming to treat or prevent Covid-19.

The list of  products being promoted online includes, ‘miracle cures’, ‘divine cleansing oils’, ‘antiviral misting sprays’, herbal remedies, vitamins , unlicensed anti-viral medicines, among others.


Lynda Scammell, Senior Enforcement Advisor at the MHRA, said people "may have heard about products claiming to treat or cure Covid-19. At this time, there is no medicine licensed specifically to treat or prevent Covid-19."

Scammell has cautioned the people that products claiming to do so are not authorised and have not undergone regulatory approvals required for sale in the UK market. She added that MHRA cannot guarantee the safety or quality of these products and this poses a risk to the health of the people.

She further said: “We have been receiving reports of ‘miracle cures’, ‘antiviral misting sprays’, antiviral medicines being sold through websites. Offering to sell unauthorised medicines is against the law.

The buyers may risk their health as they don’t have any information on the products they receive from online sellers and this could further spread the virus and increase pressure health and social care systems of the country, MHRA has said in a advice to the public.

MHRA is working alongside other law enforcement agencies to combat the criminal activities which claim treatment for Covid-19.

The advice is part of the ongoing MHRA #FakeMeds campaign which aims to encourage people who buy medical products online to make sure they are purchasing from legitimate sources.

The MHRA advises the general public to purchase from a registered pharmacy – either from the premises or online.

Registered online suppliers can be found here. If people suspect they have a dodgy medicine or medical device, they can report if via our safety monitoring system - the Yellow Card scheme.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less